FineMark National Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $441K | Sell |
3,597
-156
| -4% | -$19K | 0.01% | 331 |
|
|
2025
Q3 | $417K | Sell |
3,753
-425
| -10% | -$48.3K | 0.01% | 335 |
|
|
2025
Q2 | $463K | Buy |
4,178
+1
| +0% | +$106 | 0.02% | 307 |
|
|
2025
Q1 | $468K | Buy |
4,177
+161
| +4% | +$16.6K | 0.02% | 301 |
|
|
2024
Q4 | $371K | Buy |
4,016
+58
| +1% | +$5.22K | 0.01% | 325 |
|
|
2024
Q3 | $332K | Sell |
3,958
-924
| -19% | -$70.5K | 0.01% | 338 |
|
|
2024
Q2 | $335K | Sell |
4,882
-238
| -5% | -$15.9K | 0.01% | 331 |
|
|
2024
Q1 | $375K | Sell |
5,120
-141
| -3% | -$10.8K | 0.01% | 317 |
|
|
2023
Q4 | $426K | Sell |
5,261
-388
| -7% | -$30.2K | 0.02% | 293 |
|
|
2023
Q3 | $423K | Sell |
5,649
-84
| -1% | -$6.46K | 0.02% | 290 |
|
|
2023
Q2 | $442K | Buy |
5,733
+94
| +2% | +$7.5K | 0.02% | 293 |
|
|
2023
Q1 | $468K | Buy |
5,639
+822
| +17% | +$68.1K | 0.02% | 282 |
|
|
2022
Q4 | $414K | Sell |
4,817
-149
| -3% | -$11.8K | 0.02% | 279 |
|
|
2022
Q3 | $306K | Sell |
4,966
-843
| -15% | -$53.2K | 0.01% | 310 |
|
|
2022
Q2 | $359K | Buy |
5,809
+87
| +2% | +$5.39K | 0.02% | 311 |
|
|
2022
Q1 | $341K | Sell |
5,722
-1,348
| -19% | -$86.2K | 0.01% | 344 |
|
|
2021
Q4 | $513K | Sell |
7,070
-2,378
| -25% | -$164K | 0.02% | 301 |
|
|
2021
Q3 | $660K | Sell |
9,448
-1,889
| -17% | -$133K | 0.03% | 251 |
|
|
2021
Q2 | $781K | Sell |
11,337
-694
| -6% | -$46.3K | 0.03% | 239 |
|
|
2021
Q1 | $777K | Sell |
12,031
-87
| -0.7% | -$5.61K | 0.03% | 232 |
|
|
2020
Q4 | $706K | Buy |
12,118
+745
| +7% | +$45K | 0.03% | 233 |
|
|
2020
Q3 | $719K | Sell |
11,373
-4,542
| -29% | -$315K | 0.03% | 214 |
|
|
2020
Q2 | $1.23M | Sell |
15,915
-44
| -0.3% | -$3.37K | 0.07% | 153 |
|
|
2020
Q1 | $1.19M | Sell |
15,959
-58,748
| -79% | -$4.06M | 0.07% | 139 |
|
|
2019
Q4 | $4.85M | Sell |
74,707
-191
| -0.3% | -$12.4K | 0.24% | 91 |
|
|
2019
Q3 | $4.75M | Buy |
74,898
+13,034
| +21% | +$852K | 0.25% | 86 |
|
|
2019
Q2 | $4.18M | Buy |
61,864
+1,149
| +2% | +$75.6K | 0.23% | 90 |
|
|
2019
Q1 | $3.95M | Buy |
60,715
+1,344
| +2% | +$89.3K | 0.23% | 88 |
|
|
2018
Q4 | $3.71M | Sell |
59,371
-1,220
| -2% | -$85.3K | 0.25% | 84 |
|
|
2018
Q3 | $4.68M | Sell |
60,591
-1,890
| -3% | -$143K | 0.28% | 82 |
|
|
2018
Q2 | $4.43M | Buy |
62,481
+2,555
| +4% | +$180K | 0.27% | 87 |
|
|
2018
Q1 | $4.52M | Buy |
59,926
+1,403
| +2% | +$112K | 0.29% | 82 |
|
|
2017
Q4 | $4.19M | Buy |
58,523
+45,277
| +342% | +$3.44M | 0.27% | 87 |
|
|
2017
Q3 | $1.07M | Sell |
13,246
-8,070
| -38% | -$617K | 0.07% | 156 |
|
|
2017
Q2 | $1.51M | Sell |
21,316
-4,409
| -17% | -$293K | 0.11% | 130 |
|
|
2017
Q1 | $1.75M | Sell |
25,725
-1,916
| -7% | -$135K | 0.13% | 124 |
|
|
2016
Q4 | $1.98M | Sell |
27,641
-6,243
| -18% | -$464K | 0.16% | 112 |
|
|
2016
Q3 | $2.68M | Sell |
33,884
-20,504
| -38% | -$1.67M | 0.29% | 96 |
|
|
2016
Q2 | $4.54M | Sell |
54,388
-12,656
| -19% | -$1.12M | 0.51% | 54 |
|
|
2016
Q1 | $6.16M | Sell |
67,044
-1,191
| -2% | -$107K | 0.72% | 41 |
|
|
2015
Q4 | $6.9M | Buy |
68,235
+3,745
| +6% | +$390K | 0.82% | 33 |
|
|
2015
Q3 | $6.33M | Buy |
64,490
+9,914
| +18% | +$1.1M | 0.85% | 29 |
|
|
2015
Q2 | $6.39M | Buy |
54,576
+2,367
| +5% | +$259K | 0.83% | 27 |
|
|
2015
Q1 | $5.12M | Buy |
52,209
+10,448
| +25% | +$1.06M | 0.7% | 36 |
|
|
2014
Q4 | $3.94M | Buy |
41,761
+7,368
| +21% | +$762K | 0.58% | 46 |
|
|
2014
Q3 | $3.66M | Buy |
34,393
+2,843
| +9% | +$278K | 0.59% | 44 |
|
|
2014
Q2 | $2.62M | Buy |
31,550
+6,025
| +24% | +$469K | 0.44% | 60 |
|
|
2014
Q1 | $1.81M | Buy |
25,525
+8,045
| +46% | +$631K | 0.34% | 76 |
|
|
2013
Q4 | $1.31M | Buy |
17,480
+3,394
| +24% | +$236K | 0.27% | 104 |
|
|
2013
Q3 | $886K | Buy |
14,086
+2,409
| +21% | +$144K | 0.22% | 114 |
|
|
2013
Q2 | $599K | Buy |
+11,677
| New | +$609K | 0.18% | 110 |
|
Other funds holding GILD
FineMark National Bank & Trust's GILD Position: Q4 2025 in Review
FineMark National Bank & Trust reduced its Gilead Sciences (GILD) stake by 4.2% in Q4 2025, selling an estimated $19K and leaving 3,597 shares worth $441K. The position accounts for 0.01% of the portfolio, ranked #331.
FineMark National Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $6.9M in Q4 2015. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- FineMark National Bank & Trust held 3,597 shares of Gilead Sciences worth $441K as of Q4 2025.
- FineMark National Bank & Trust sold 156 Gilead Sciences shares in Q4 2025, an estimated $19K.
- Gilead Sciences made up 0.01% of FineMark National Bank & Trust's portfolio in Q4 2025, its #331 holding.
- FineMark National Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- FineMark National Bank & Trust's Gilead Sciences position peaked at $6.9M in Q4 2015.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on FineMark National Bank & Trust's 13F filing for Q4 2025, filed 12 Feb 2026.